Mar 22 | Sep 21 | Mar 21 | Sep 20 | Mar 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 8.81M | $ 5.96M | $ 17.98M | $ 12.41M | $ 4.61M |
Total Assets | $ 1.16B | $ 1.14B | $ 1.13B | $ 1.09B | $ 1.06B |
Total Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Net Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Total Liabilities | $ 847.02M | $ 847.76M | $ 831.46M | $ 818.65M | $ 764.74M |
Stockholders Equity | $ 281.63M | $ 261.63M | $ 265.56M | $ 247.81M | $ 261.88M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |